COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,510 Articles (22,870 medRxiv, 8,640 bioRxiv)

Most recent first Previous |  Page 1763: Articles 17621-17630  | Next

A Simple RT-PCR Melting temperature Assay to Rapidly Screen for Widely Circulating SARS-CoV-2 Variants.
Banada, P. P., Green, R., Banik, S., Chopoorian, A., Streck, D., Jones, R., Chakravorty, S., Alland, D.
10.1101/2021.03.05.21252709 — Posted: 2021-03-08
More than the eye can see; shedding new light on SARS-CoV-2 Lateral Flow Device-based immunoassays
Koller, G., Morrell, A. P., Galao, R., Pickering, S., MacMahon, E., Johnson, J., Ignatyev, K., Neil, S. J., Elsharkawy, S., Fleck, R., Machado, P., Addison, O.
10.1101/2021.03.06.21253048 — Posted: 2021-03-08
COVID-19 mRNA vaccine is not detected in human milk
Golan, Y., Prahl, M., Cassidy, A., Lin, C. Y., Ahituv, N., Flaherman, V. J., Gaw, S. L.
10.1101/2021.03.05.21252998 — Posted: 2021-03-08 Discussion: Onsite
Elevated mortality among people experiencing homelessness with COVID-19
Leifheit, K. M., Chaisson, L. H., Medina, J. A., Wahbi, R., Shover, C. L.
10.1101/2021.03.05.21253019 — Posted: 2021-03-08
SARS-CoV2 sero-survey among adults involved in health care and health research in Guinea-Bissau, West Africa
Benn, C. S., Salinha, A., Mendes, S., Cabral, C., Martins, C., Nielsen, S., Fisker, A. B., Schaltz-Buchholzer, F., Joergensen, C. S., Aaby, P.
10.1101/2021.03.06.21253046 — Posted: 2021-03-08
Long-Term Duration of Antibody Response to SARS CoV-2 in One of the Largest Slums of Buenos Aires
Pagotto, V., Luna, L., Salto, J., Wagner Manslau, M., Figar, S., Mistchenko, A., Carciofi Boyero, G., Weinberger, N., COVIDAR Group, , Gomez Saldano, A. M., Alpire Alponte, C., Auza Alarcon, P., Copa Tarqui, A., Cortez, S., Gallardo, P., Gemio Pinaya, J., Hernandez Navarro, A., Maccio, A., Mosqueda, P., Neme, N., Quispe, B., Ramirez Bernal, E., Soria, T., Fernandez Arce, A., Gamarnik, A., Gonzalez Bernaldo de Quiros, F.
10.1101/2021.03.05.21253010 — Posted: 2021-03-08
Investigating the first wave of the COVID-19 pandemic in Ukraine using epidemiological and genomic sequencing data
Gankin, Y., Koniukhovskii, V., Nemira, A., Chowell, G., Weppelmann, T. A., Skums, P., Kirpich, A.
10.1101/2021.03.05.21253014 — Posted: 2021-03-08
Anti-Spike protein assays to determine post-vaccination antibody levels: a head-to-head comparison of five quantitative assays
Perkmann, T., Perkmann-Nagele, N., Koller, T., Mucher, P., Radakovics, A., Marculescu, R., Wolzt, M., Wagner, O. F., Binder, C. J., Haslacher, H.
10.1101/2021.03.05.21252977 — Posted: 2021-03-08
Centenarians and extremely old people living with frailty can elicit durable SARS-CoV-2 spike specific IgG antibodies with virus neutralization functions following virus infection
Foley, M. K., Searle, S. D., Toloue, A., Booth, R., Falkenham, A., Falzarano, D., Rubino, S., Francis, M., McNeil, M., Richardson, C., LeBlanc, J. J., Oldford, S., Gerdts, V., Andrew, M. K., McNeil, S., Clarke, B., Rockwood, K., Kelvin, D. J., Kelvin, A. A.
10.1101/2021.03.05.21252707 — Posted: 2021-03-08
First dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in ex COVID-19 subjects
Mazzoni, A., Di Lauria, N., Maggi, L., Salvati, L., Vanni, A., Capone, M., Lamacchia, G., Mantengoli, E., Spinicci, M., Zammarchi, L., Kiros, S. T., Colao, M. G., Parronchi, P., Scaletti, C., Turco, L., Liotta, F., Rossolini, G. M., Cosmi, L., Bartoloni, A., Annunziato, F., COVID-19 Research Group
10.1101/2021.03.05.21252590 — Posted: 2021-03-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).